# Nitrate chlorides

Nitrate chlorides are mixed anion compounds that contain both nitrate (NO$_3$$^−$) and chloride (Cl$^−$) ions. Various compounds are known, including amino acid salts, and also complexes from iron group, rare-earth, and actinide metals. Complexes are not usually identified as nitrate chlorides, and would be termed chlorido nitrato complexes.

## Formation

Nitrate chloride compounds may be formed by mixing solutions of chloride and nitrate slats, the addition of nitric acid to a chloride salt solution, or the addition of hydrochloric acid to a nitrate solution. Most commonly water is used as a solvent, but other solvents such as methylene dichloride, methanol or ethanol can be used.

## Minerals

| name | formula | ratio NO$_3$:Cl | system | space group | unit cell Å | volume | density | optical |
| Buttgenbachite | Cu$_{19}$(NO$_3$)$_2$(OH)$_{32}$Cl$_4$ · 2H$_2$O | 2:4 | hexagonal | P6$_3$/mmc | a = 15.75 Å, c = 9.161 Å Z=1 | 1968 | 4.538 | Blue Uniaxial (+) n$_ω$ = 1.738 n$_ε$ = 1.752 birefringence: δ = 0.014 |
| Lislkirchnerite | Pb$_6$Al(OH)$_8$Cl$_2$(NO$_3$)$_5$·2H$_2$O | 5:2 | monoclinic | P2$_1$/n | a = 10.7834(6) Å, b = 9.0584(5) Å, c = 13.6178(9) Å β = 102.28(2)° | 1300 | | |
| Sveite | KAl$_7$(NO$_3$)$_4$(OH)$_{16}$Cl$_2$ · 8H$_2$O | 4:2 | Monoclinic | | a = 10.89 Å, b = 13.04 Å, c = 30.71 Å β = 92.1° | 4,358 | | white Biaxial (+) n$_α$ = 1.501 n$_β$ = 1.503 n$_γ$ = 1.535 2V: calculated = 30° Max Birefringence = δ = 0.034 |
| | Pb$_8$O$_3$(OH)$_5$(NO$_3$)$_4$Cl | 4:1 | Monoclinic | | a = 14.831(3) Å, b = 7.659(2) Å, c = 10.186(2) Å β = 108.64(3)° | 1096 | | colourless |

## List

| name | formula | ratio NO$_3$:Cl | mw | system | space group | unit cell Å | volume | density | comment |
| Chlorine nitrate | O$_2$NOCl | | | orthorhombic | P2$_1$2$_1$2$_1$ | a = 3.856 b = 6.755 c = 12.07 Z=46 | 314.5 | 2.058 | at −166 °C (related compound) |
| anilinium chloride nitrate | (C$_6$H$_8$N)$_2$ClNO$_3$ | 1:1 | | triclinic | P1 | a = 8.418 b = 9.648 c = 10.036 α = 62.993° β = 86.798° γ = 72.999° | | | |
| o-Phenylenediaminium chloride nitrate | | | | orthorhombic | Pnma | a = 7.3695 b = 8.2367 c = 14.2398 Z=4 | 864.36 | 1.596 | |
| l-lysinium(2+) chloride nitrate | L-Lys$^{2+}$·Cl$^−$·NO$_3$$^−$ | 1:1 | | monoclinic | P2$_1$ | a 8.8022 b 7.0096 c 20.2169 β 95.226° | | | |
| L-Lysine L-lysinium dichloride nitrate | 2C$_6$H$_{15}$N$_2$O$_2$$^+$·H$^+$·NO$_3$$^−$·2Cl$^−$ | 1:2 | 428.32 | orthorhombic | P2$_1$2$_1$2$_1$ | a 4.9846 b 20.604 c 20.663 Z=4 | 2122.1 | 1.341 | colourless |
| L-cysteinium sodium nitrate chloride | | 1:1 | | monoclinic | P2$_1$ | a=18.5, b=5.22, c=7.22 β=103.83° | 678 | | transparent from 328 to 1400nm; SHG 0.51 ×KDP |
| Bis(L-ornithinium) chloride nitrate sulfate | 2C$_5$H$_{14}$N$_2$O$_2$$^{2+}$·Cl$^−$·NO$_3$$^−$·SO$_4$$^{2-}$ | | 461.88 | monoclinic | C2 | a 13.872 b 9.578 c 9.178 β 125.35° Z=2 | 994.6 | 1.542 | |
| (μ$_4$-octahydroxycucurbit(5)uril)-(μ$_2$-nitrato)-aqua-di-potassium chloride nonahydrate | {[K(H$_2$O)](NO$_3$⊂C$_{30}$H$_{28}$N$_{20}$O$_{20}$)[K(η$^2$-NO$_3$)]}Cl(H$_3$O)$_2$$^{2+}$·7H$_2$O | | | monoclinic | P2$_1$/c | a 13.8265 b 14.2642 c 25.143 β 92.711° Z=4 | 4953.2 | 1.806 | colourless |
| Thecotrichite | Ca$_3$(CH$_3$COO)$_3$Cl(NO$_3$)$_2$ • 6H$_2$O | 2:1 | | monoclinic | P2$_1$/c | a 23.5933 b 13.8459 c 6.8010 β 95.195° Z=4 | 2212.57 | | anthropogenic, formed on ceramics in damp wooden cupboards; refractive index: n$_x$ = 1.491 n$_z$ = 1.494 stable to 110°C |
| di-μ-hydroxido-bis[triaqua(nitrato-κ$^2$O,O′)scandium(III)] dichloride | [Sc$_2$(NO$_3$)$_2$(OH)$_2$(H$_2$O)$_6$]Cl$_2$ | 1:1 | 426.95 | triclinic | P1 | a=6.7221 b=7.6279 c=8.5181 α=100.904° β=110.125° γ=102.329° Z=1 | 383.87 | 1.847 | colourless @100K |
| | [Fe(Cl)$_4$](Fe(NO$_3$)$_2$(OPPh$_2$py)$_2$ | | | | | | | | |
| | [Fe(NO$_3$)$_2$(Cl)(OPPh$_2$py)]· CH$_2$Cl$_2$ | | | monoclinic | P2$_1$/n | a 9.138 b 15.69 c 16.68 β 94.50° | | | |
| hexamethylphosphoric triamide | Fe(NO$_3$)$_2$(Cl)(HMPA)$_{1.5}$ | | | | | | | | |
| hexamethylphosphoric triamide | Fe(NO$_3$)$_2$(Cl)(HMPA)$_2$ | | | | | | | | |
| hexamethylphosphoric triamide | Fe(NO$_3$)(Cl)$_2$(HMPA)$_2$ | | | monoclinic | P2$_1$/c | a 15.994 b 10.172 c 16.571 β 104.7° | | | |
| pypn=N,N′-bis(2-pyridylmethyl)-1,3-propanediamine (N,N'-bis((pyridin-2-yl)methyl)propane-1,3-diamine)-dichloro-iron(iii) nitrate | [Fe(pypn)Cl$_2$](NO$_3$) | | | monoclinic | P2$_1$/c | a 11.848 b 12.474 c 12.301 β 94.56° | | | Cl in cis position |
| pentaamminenitrocobalt(III) chloride nitrate | [Co(NH$_3$)$_5$NO$_2$](NO$_3$)Cl | | | orthorhombic | Pnam | a 14.814 b 9.623 c 7.309 | | | @290K; photosalient (jumps under UV) |
| trans-Dichloro-bis(ethylenediamine)-cobalt(III) nitrate | [Co en$_2$Cl$_2$]NO$_3$ | | | monoclinic | P2$_1$/n | a = 6.348 b = 9.304 c = 9.853 β = 101.79° | 569.6 | 1.82 | green |
| cis-Chloro(ammine)bis(ethylenediamine)cobalt dinitrate | [Co(en)$_2$(NH$_3$)Cl](NO$_3$)$_2$ | | | | | | | | |
| trans-Chloro(ammine)bis(ethylenediamine)cobalt dinitrate | [Co(en)$_2$(NH$_3$)Cl](NO$_3$)$_2$ | | | | | | | | |
| 5-nitrosalicyliddineaminato tetraamino cobalt dichloride nitrate | | | | | | | | | orange |
| cis-Chlorobis(ethylenediamine)dodecylaminecobalt(III) nitrate | cis-[Co(en)$_2$(C$_{12}$H$_{25}$NH$_2$)Cl](NO$_3$)$_2$ | | | | | | | | |
| bis(1,4,7-triazacyclononane) nickel(ii) nitrate chloride monohydrate | [Ni([9]aneN$_3$)$_2$](NO$_3$)Cl·H$_2$O | | | orthorhombic | Pna2$_1$ | a 17.584 b 8.860 c 12.141 | | | |
| Bis[chlorobis(1,10-phenanthroline-N,N')(thiourea-S)nickel(II)] chloride nitrate diethanol solvate | [NiCl(C$_{12}$H$_8$N$_2$)$_2$(CH$_4$N$_2$S)]$_2$(NO$_3$)Cl·­2C$_2$H$_6$O | | | orthorhombic | Fdd2 | a 22.813 b 29.024 c 17.113 Z=8 | 11331 | 1.467 | blue |
| Cucurbit[8]uril (1-n-butyl-4,4'-bipyridin-1-ium 1-n-butyl-4,4'-bipyridin-1-ium-penta-aqua-nickel(ii)) clathrate chloride trinitrate undecahydrate | {[C$_{14}$H$_{17}$N$_2$Ni(H$_2$O)$_5$]$_2$⊂C$_{48}$H$_{48}$N$_{32}$O$_{16}$}[(C$_{14}$H$_{17}$N$_2$)$_2$⊂C$_{48}$H$_{48}$N$_{32}$O$_{16}$]Cl$_2$(NO$_3$)$_6$·22H$_2$O | | | triclinic | P1 | a 16.671 b 16.678 c 20.442 α 112.772° β 101.844° γ 90.102° | | | |
| bis(bis(1,4,7-triazacyclonon-1-yl)pentane)-di-nickel(ii) trichloride nitrate pentadecahydrate | [Ni$_2$(EM5)$_2$]Cl$_3$NO$_3$·15H$_2$O | | | orthorhombic | Pbcn | a 28.030 b 17.469 c 12.289 | | | |
| bis(bis(1,4,7-triazacyclonon-1-yl)hexane)-di-nickel(ii) dichloride dinitrate hexahydrate | [Ni$_2$(EM6)$_2$]Cl$_3$(NO$_3$)$_2$·6H$_2$O | | | triclinic | P1 | a 9.529 b 9.566 c 14.684 α 81.08° β 78.84° γ 88.82° | | | |
| dapsc = 2,6-diacetylpyridine-bis(semicarbazone)) | [Ni(dapsc)(H$_2$O)$_2$]Cl(NO$_3$)·H$_2$O | | | triclinic | P1 | a=6.9130 b=12.3410 α=114.8010 β=93.946 γ=103.7760 Z=2 | 933.10 | 1.735 | green |
| hexakis(1H-imidazole)-nickel(ii) chloride nitrate tetrahydrate | [Ni(Im)$_6$][(NO$_3$)Cl(H$_2$O)$_4$] | | | hexagonal | P6$_3$m | a 9.003 c 21.034 | | | |
| bis(M-2-chloro)-(nitrato-o)-(2,2 '-bipyridine-N.N ')-copper(II) | Cu(2,2 '-BP)Cl NO$_3$ | | | triclinic | P1 | a = 7.515 b = 9.253 c = 10.283 α=112.181° β= 102.155° γ= 105.617° Z=2 | 597.4 | 1.769 | green; dimer |
| bis(M-2-chloro)-(nitrato-o)-(2,2 '-4,4'-dimethylbipyridine-N.N ')-copper(II) | Cu(2, 2'-dmBP)ClNO$_3$ | | | | | | | | dimer |
| Chloro(1,10-phenanthroline-2-carboxamide oxime)copper(II) Nitrate | | | | | | | | | |
| bis(μ$_2$-2,4,4,6,6-pentakis(2-pyridyloxy)cyclo-2,4,6-triphosphazene 2-oxide)-dichloro-nitrato-cobalt(ii)-di-copper chloride | [{(N$_3$P$_3$(OC$_5$H$_4$N)$_5$(O)CuCl)$_2$Co(NO$_3$)}Cl] | | | orthorhombic | Fddd | a =22.639 b =28.202 c =45.260 | | | |
| Copper(II)–sparteine nitrate chloride | Cu$^{II}${(−)Sp}(NO$_3$)Cl | | | orthorhombic | P2$_1$2$_1$2$_1$ | a 16.370 b 13.334 c 7.6803 | | | |
| Cucurbit[8]uril (1-n-butyl-4,4'-bipyridin-1-ium 1-n-butyl-4,4'-bipyridin-1-ium-penta-aqua-copper(ii)) clathrate dichloride dinitrate hexadecahydrate | {[C$_{14}$H$_{17}$N$_2$Cu(H$_2$O)$_5$]$_2$⊂C$_{48}$H$_{48}$N$_{32}$O$_{16}$}[(C$_{14}$H$_{17}$N$_2$)$_2$⊂C$_{48}$H$_{48}$N$_{32}$O$_{16}$]Cl$_4$(NO$_3$)$_4$·32H$_2$O | | | triclinic | P1 | a 16.607 b 17.093 c 20.509 α 66.003° β 77.568° γ 89.155° | | | |
| copper(II)-di-2-pyridylamine complex chloride nitrate (μ$_2$-Chloro)-(nitrato-O)-(bis(2-pyridyl)amine-N,N')-copper(ii) hemihydrate | [Cu(dipyam)Cl(NO$_3$)].0.5H$_2$O | | | monoclinic | P2$_1$/a | a 7.382 b 21.494 c 8.032 β 94.26 | | | |
| tipa=tri(4-imidazolylphenyl)amine (μ$_3$-tris(4-(Imidazol-1-yl)phenyl)amine)-chloro-zinc nitrate dimethylformamide solvate | [Zn(tipa)Cl]⋅NO$_3$⋅2 DMF | | | orthorhombic | Pnna | a=28.470 b=27.784 c=9.255 | 7321 | 1.044 | |
| | Na$_3$Rb$_6$(CO$_3$)$_3$(NO$_3$)$_2$Cl·(H$_2$O)$_6$ | 2:1 | 1029.39 | hexagonal | P6$_3$/mcm | a = 9.5732 c = 15.820 Z=2 | 1255.6 | 2.723 | UV cut off 231 nm; uniaxial; birefringence 0.14 @ 546 nm |
| | KRb$_2$(NO$_3$)$_2$Cl | 2:1 | 369.51 | orthorhombic | pbam | a=12.1863 b=12.4072 c=5.8203 Z=4 | 880.02 | 2.789 | transparent; birefringence = 0.084 at 1064 nm |
| | [Ru(NH$_3$)$_5$Cl](NO$_3$)$_2$ | | | tetragonal | I4 | a = 7.5811 b = 7.5811 c = 10.535 | 605.5 | 1.896 | yellow |
| | [RuNO(NH$_3$)$_3$(H$_2$O)Cl](NO$_3$)$_2$ | | | monoclinic | Cc | a = 13.7924 b = 6.9114 c = 12.3577 β = 111.863° Z = 4 | 1093.27 | 2.185 | |
| bis((μ$_2$-chloro)-(nitrato)-(η$^5$-pentamethylcyclopentadienyl)-rhodium(iii)) | [Cp*Rh(η$^1$-NO$_3$)(μ-Cl)]$_2$ | | | monoclinic | P2$_1$/n | a 8.3874 b 10.4549 c 14.8585 β 104.385° | | | |
| chloro-(cyclohexylisocyano)-(η$^5$-pentamethylcyclopentadienyl)-(triphenylphosphine)-rhodium nitrite nitrate dihydrate | {[Cp*RhCl(PPh$_3$)(CNC$_6$H$_{11}$)]$_2$(NO$_2$)(NO$_3$)}·2H$_2$O | | | triclinic | P1 | a 10.319 b 10.5582 c 17.371 α 97.011° β 94.35° γ 112.154° | | | |
| | [Rh(NH$_3$)$_5$Cl](NO$_3$)$_2$ | | | tetragonal | I4 | a = 7.5858 b = 7.5858 c = 10.41357 Z=2 | 599.24 | 1.926 | yellow |
| bis(μ$_2$-4'-(4-pyridyl)-2,2':6',2''-terpyridine)-bis(η$^5$-pentamethylcyclopentadienyl)-tetra-chloro-di-rhodium-nickel dinitrate methanol solvate dihydrate | {Cp*$_2$Rh$_2$[Ni(pyterpy)$_2$]Cl$_4$}(NO$_3$)$_2$ | | | monoclinic | C2/c | a 53.4454 b 8.8419 c 33.7700 β 112.029° | | | |
| cis-dichlorobis(ethylenediamine)rhodium(III) nitrate | [Rh(en)$_2$Cl$_2$]NO$_3$ | | | triclinic | P1 | a=8.619 b=6.528 c=11.687 α=I02.18 β=90.98 γ=112.46 Z=2 | 590.5 | 2.00 | yellow |
| trans-dichlorobis(ethylenediamine)rhodium(III) nitrate | [Rh(en)$_2$Cl$_2$]NO$_3$ | | | monoclinic | P2$_1$/n | a = 6.441 b=9.281 c=10.010 β=102.42 Z=2 | 584.4 | 2.02 | orange |
| L=3,6,9,16,19,22-hexaazatricyclo[22.2.2.2$^{11,14}$]triacon-11,13,24,26(1),2 7,29-hexaene (μ$_2$-3,6,9,16,19,22-Hexa-azatricyclo(22.2.2.2$^{11,14}$)triaconta-1(26),11,13,24,27,29-hexaene)-dichloro-di-palladium(ii) dinitrate monohydrate | [Pd$_2$LCl$_2$](NO$_3$)$_2$·H$_2$O | | | monoclinic | P2/c | a 21.744 b 9.243 c 16.259 β 93.580° | | | |
| en=Ethylenediamine py=pyridine | [Pd(en)(py)Cl]NO$_3$ | | | monoclinic | P2$_1$/c | a = 7.990, b = 16.058, c = 9.846 β = 103.81° Z = 4 | | | |
| 4-Methylpyridine, | [Pd(en)(4-Me-py)Cl]NO$_3$ | | | | | | | | |
| 4-hydroxy-pyridine | [Pd(en)(4-OH-py)Cl]NO$_3$ | | | | | | | | |
| 4-NH$_2$-py=4-aminopyridine | [Pd(en)(4-NH$_2$-py)Cl]NO$_3$ | | | | | | | | |
| tetrakis(μ-tris((diphenylphosphino)methyl)amine)-tetrachloro-pentadeca-silver tris(nitrate) octahydrate | [Ag$_{15}$(N-triphos)$_4$(Cl$_4$)](NO$_3$)$_3$ | | 3649.32 | orthorhombic | C222$_1$ | a 18.702 b 36.975 c 28.652 Z=6 | 19813 | 1.835 | |
| bis(tetrakis(Triphenylphosphine)-silver) chloro-diphenyl-bis(nitrato-O,O')-tin diphenyl-tris(nitrato-O,O')-tin | [Ag(PPh$_3$)$_4$][SnPh$_2$(NO$_3$)$_2$(Cl,NO$_3$)] | | | triclinic | P1 | a 22.43 b 14.13 c 13.96 α 90.59° β 69.82° γ 64.58° | | | |
| barium chloride nitrate | Ba(NO$_3$)Cl | | | orthorhombic | Pnma | a 8.9108 b 5.2991 c 8.3414 | | | UV cutoff 213 nm; birefringence 0.009 @ 1064 nm |
| L$_{SS=}$trans-N,N′-bis(salicylidene)-(1S,2S)-cyclohexanediamine | [La(H$_2$L$_{SS}$)(NO$_3$)$_2$Cl]·2CH$_2$Cl$_2$ | | | tetragonal | P4$_3$2$_1$2 | a = 18.1798 c = 16.4174 Z=4 | 5426.0 | 1.150 | |
| tris(μ$_2$-N',N''-((5-Chloro-2-oxy-1,3-phenylene)dimethylylidene)bis(benzohydrazide))-bis(ethanol)-di-lanthanum dinitrate chloride acetone solvate dihydrate | [La$_2$(H$_2$L$^1$)$_3$(C$_2$H$_5$OH)$_2$]·(Cl)·(NO$_3$)$_2$·((CH$_3$)$_2$CO)$_2$·(H$_2$O)$_2$ | | | monoclinic | C2/c | a 21.1020 b 18.5070 c 23.1880 β 114.452° | | | |
| L$_{SS=}$trans-N,N′-bis(salicylidene)-(1S,2S)-cyclohexanediamine | [Ce(H$_2$L$_{SS}$)(NO$_3$)$_2$Cl]·2CH$_2$Cl$_2$ | | | tetragonal | P4$_3$2$_1$2 | a = 18.216 c = 16.483 Z=4 | 5469.6 | 1.147 | |
| Chloro-nitrato-pentakis(tetrahydrofuran)-cerium(iii) pentachloro-(tetrahydrofuran)-cerium(iv) | [CeCl(NO$_3$)(THF)$_5$]$^+$[CeCl$_5$(THF)]$^−$ | | | monoclinic | P2/c | a 12.138 b 11.299 c 14.066 β 104.31° | | | |
| Praseodymium dichloride nitrate pentahydrate | [PrCl$_2$(H$_2$O)$_6$][PrCl$_2$(NO$_3$)$_2$(H$_2$O)$_4$] | | | monoclinic | P2/c | a = 12.288 b = 6.484 c = 12.660 β = 91.91° Z = 4 | | | green |
| L=N,N′‐bis (salicylidene)‐1,2‐cyclohexanediamine | [Pr(H$_2$L)$_2$(NO$_3$)$_2$Cl]·2CH$_2$Cl$_2$ | | 941.14 | tetragonal | P4$_3$2$_1$2 | a=18.0936 c=16.3490 Z=4 | 5352.3 | 1.168 | |
| L$_{SS=}$trans-N,N′-bis(salicylidene)-(1S,2S)-cyclohexanediamine | [Nd(H$_2$L$_{SS}$)(NO$_3$)$_2$Cl]·2CH$_2$Cl$_2$ | | | tetragonal | P4$_3$2$_1$2 | a = 18.1041 c = 16.4374 Z=4 | 5387.5 | 1.164 | |
| Chloro-bis(nitrato-O,O')-bis(tetramethyl (t-butyl(hydroxy)methylene)-bis(phosphonate)-O,O')-neodymium(iii) | NdCl(NO$_3$)$_2${[(MeO)$_2$PO]$_2$C(OH)$^t$Bu}$_2$ | | | monoclinic | P2$_1$/a | a 17.0961 b 9.3040 c 24.4989 β 110.244° | | | |
| tri-sodium hexakis(μ-oxo)-tetraoctacontakis(μ-hydroxo)-triacontakis(μ-2-thiophenecarboxylato)-tetrakis(2-thiophenecarboxylato)-decakis(μ-glycinato)-diglycine-docosa-aqua-octatetraconta-europium(iii) nitrate hexachloride 2-thiophenecarboxylic acid pentahydrate | Na$_3$[Eu$_{48}$O$_6$(OH)$_{84}$(tca)$_{34}$(gly)$_{12}$(H$_2$O)$_{22}$]·2Htca·6Cl·6H$_2$O·NO$_3$ | | 15118.80 | triclinic | P1 | a 20.720 b 23.227 c 24.562 α 88.66° β 71.76° γ 63.57° Z=1 | 9960 | 2.500 | |
| sodium tetradecakis(μ-3-hydroxy-2-(hydroxymethyl)-2-methylpropanoato)-hexakis(μ-oxo)-tetraoctacontakis(μ-hydroxo)-octadecakis(μ-2-thiophenecarboxylato)-octakis(2-thiophenecarboxylato)-tetracosa-aqua-octatetraconta-terbium(iii) nitrate octakis(chloride) | Na[Tb$_{48}$O$_6$(OH)$_{84}$(fca)$_{26}$(dmp)$_{14}$(H$_2$O)$_{24}$]·4Hfca·NO$_3$·8Cl | | 15154.02 | monoclinic | P2$_1$/n | a 24.0145 b 32.9221 c 25.6605 β 97.521° Z=2 | 20112.9 | 2.490 | |
| L=2-methyl-8-hydroxyquinoline tetrakis(μ-2-methylquinolin-8-olato)-(μ-chloro)-ethanol-dinitrato-di-nickel(ii)-dysprosium(iii) acetonitrile solvate | [Ni$_2$$^{II}$Dy$^{III}$(EtOH)(L$^2$)$_4$(NO$_3$)$_2$Cl] ⋅ CH$_3$CN | | | triclinic | P1 | a 11.1201 b 14.1566 c 15.448 α 78.625° β 73.918° γ 81.055° | | | |
| (tetrakis(μ-(1-phenylethyl)ammoniomethylphosphonato)-chloro-nitrato-di-erbium | R- or S-[Er$_2$(pempH)$_4$(NO$_3$)Cl] | | | orthorhombic | P2$_1$2$_1$2 | a 15.986 b 32.069 c 9.1593 | | | quadruple stranded helix |
| | [{trans-PtCl(NH$_3$)$_2$}{μ-(H$_2$N(CH$_2$)$_6$NH$_2$)}{trans-PdCl(NH$_3$)$_2$](NO$_3$)Cl | | | | | | | | yellow |
| | [{trans-PtCl(NH$_3$)$_2$}2{trans-Pt(thiazole)$_2$}{H$_2$N(CH2)$_6$NH$_2$}$_2$]Cl$_3$(NO$_3$) | | | | | | | | |
| | [PtPy$_2$(NH=CH-OH)Cl$_3$]NO$_3$ | | | orthorhombic | P2$_1$2$_1$2$_1$ | a = 10.381 b = 11.776 c = 13.848 Z = 4 | 1692.9 | | |
| alpha pyridone | cis-[Pt(NH3)2(C5H4NOH)Cl](NO3) | | | triclinic | P1 | a=10.706 b=12.552 c=4.151 α =95.57° β=92.32° γ=99.05° Z=2 | 547.4 | 2.558 | white needles |
| [Pt$^{IV}$(trans-1R,2R-diaminocyclohexane)trans-(acetate)$_2$(9-ethylguanine)Cl]NO$_3$ · H$_2$O | | | | | P2$_1$ | a = 10.446 b = 22.906 c = 10.978 Z = 4 | | | |
| Chloro-(homopiperazine)-(diphenylsulfido)-platinum(ii) nitrate | [Pt$^{II}$(homopiperazine)(diphenylsulfide)Cl]NO$_3$ | | | monoclinic | P2$_1$/c | a 17.666 b 8.812 c 12.619 β 101.02° | | | |
| mmap=1-methyl-4-(methylamino)piperidine | [Pt(mmap)(CH$_3$)$_2$S)Cl](NO$_3$) | | | | | | | | white |
| dhq=decahydroquinoline | [Pt(dhq)(CH$_3$)$_2$S)Cl](NO$_3$) | | | | | | | | |
| | [La(NO$_3$)$_2$(H$_2$O)$_6$]$_2$[PtCl$_6$]·2H$_2$O | | | monoclinic | P2$_1$/c | a = 6.974 b = 16.545 c = 13.177 β = 93.97° Z=2 | | | yellow |
| | [Pr(NO$_3$)$_2$(H$_2$O)$_6$]$_2$[PtCl$_6$]·2H$_2$O | | | monoclinic | P2$_1$/c | a = 6.955 b = 16.525, c = 13.18.5 β = 93.93° Z=2 | | | yellow |
| | [Gd(NO$_3$)(H$_2$O)$_7$][PtCl$_6$]·4H$_2$O | | | monoclinic | P2$_1$/n | a = 8.3872 b = 21.3198 c = 11.4263 β = 95.670° Z=4 | | | yellow |
| | [Dy(NO$_3$)(H$_2$O)$_7$][PtCl$_6$]·4H$_2$O | | | monoclinic | P2$_1$/n | a = 8.3840 b = 21.3950 c = 11.4310 β = 95.698° Z=4 | | | yellow |
| | Ir[NO$_3$]$_2$Cl[NH$_3$]$_5$ | | | tetragonal | I4 | a = 7.6061 c = 10.4039 | 601.89 | 2.410 | yellow |
| | {Cp*$_2$Ir$_2$[Ni(pyterpy)$_2$]Cl$_4$}(NO$_3$)$_2$ | | | | | | | | |
| Dichloro(ethylenediamine)gold(III) nitrate | [Au(NH$_2$CH$_2$CH$_2$NH$_2$)Cl$_2$]NO$_3$ | | | orthorhombic | Pbca | a = 10.338 b = 8.2105 c = 19.625 Z=8 | | | |
| (2,2'-Bipyridine)dichlorogold(III) nitrate | [AuCl$_2$(C$_{10}$H$_8$N$_2$)]NO$_3$ | | 486.06 | monoclinic | C2/c | a 6.9240 b 14.0460 c 13.0560 β 96.562° Z=4 | 1261.44 | 2.559 | pale yellow |
| Bis(methy1 L-cysteineato)mercury(II) hydrochloride hydronitrate monohydrate | (C$_4$H$_9$NO$_2$S)$_2$ClHgNO$_3$•H$_2$O | | | | | | | | |
| chloronitrato-2-{2′-[(1′-methyl)benzimidazolyl]}- 4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxidemercury(II) – mercury(II)chloride | HgCl(NO$_3$)(C$_{15}$H$_{19}$N$_4$O$_2$) · HgCl$_2$ | | | triclinic | P1 | a=9.922 b=10.822 c=11.460 α=107.518° β=102.046° γ=96.639° Z=2 | 1126.5 | | black |
| caesium mercuric nitrate chloride | CsHgNO$_3$Cl$_2$ | 1:2 | 466.41 | hexagonal | P6$_3$/mmc | a=5.8817 c=11.3920 Z=2 | 341.30 | 4.538 | birefringent Δn = 0.145@546 nm |
| 4-chloropyridinium | (C$_5$H$_5$NCl)$_2$[UO$_2$Cl$_3$(NO$_3$)] | 1:3 | | triclinic | P1 | a=6.819 b=10.781 c=14.252 α=72.890° β=80.394° γ=74.456° Z=2 | 960.3 | 2.308 | |
| 4-bromopyridinium | (C$_5$H$_5$NBr)$_2$[UO$_2$Cl$_3$(NO$_3$)] | 1:3 | 756.41 | monoclinic | P2$_1$/m | a =9.739 b =16.484 c =12.950 β =102.360° Z=4 | 2030.8 | 2.474 | |
| 4-iodopyridinium | (C$_5$H$_5$NI)$_3$[UO$_2$Cl$_3$(NO$_3$)](NO$_3$) | 2:3 | 559.20*2 | monoclinic | P2$_1$/c | a =7.9797 b =25.043 c =14.730 β =103.019° Z=4 | 2868.0 | 2.590 | |
| pyr$_2$phen = N,N′-bis-(pyridoxylideneiminato)$^{2−}$phenylene (N-(3-Hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-ylmethylidene)-N'-(5-(hydroxymethyl)-2-methyl-3-oxypyridin-4-ylmethylidene)-o-phenylenediamine-N,N',O,O')-chloro-dioxo-uranium nitrate dihydrate | [UO$_2$(H$_2$pyr$_2$phen)Cl]NO$_3$ | | | triclinic | P1 | a 9.231 b 11.855 c 14.026 α 114.8° β 94.012° γ 97.95° | | | |
| | K$_3$[(UO$_2$)(NO$_3$)Cl$_3$](NO$_3$) | | | monoclinic | P2$_1$ | a 7.8596 b 15.8675 c 10.6823 β 90.141° Z=4 | 1332.21 | 3.08 | |
| | Cs$_2$(UO$_2$)(NO$_3$)Cl$_3$ | 1:3 | 704.21 | monoclinic | P2$_1$/n | a=10.375 b=9.468 c=12.553 β= 110.280 Z=4 | 1156.7 | 4.04 | lemon yellow |
| bis(4-iodo-pyridinium) dinitrato-tetrachloro-plutonium(iv) | (C$_5$H$_5$NI)$_2$[Pu(IV)Cl$_4$(NO$_3$)$_2$] | | | triclinic | P1 | a =9.8096 b=10.1402 c=11.5033 73.416 82.364 87.100 Z=2 | 1086.8 | 2.811 | orange |
| bis(pyridinium) trinitrato-trichloro-plutonium(iv) | (C$_5$H$_6$N)$_2$[Pu(IV)Cl$_3$(NO$_3$)$_3$] | | 694.60 | monoclinic | P2$_1$/c | a 17.268 b 7.7622 c 15.112 β 97.598° Z=4 | 2007.8 | 2.298 | dark red |
| bis(4-chloro-pyridinium) dioxo-trichloro-nitrato-plutonium(vi) | (C$_5$H$_5$NCl)$_2$[Pu(VI)O$_2$Cl$_3$(NO$_3$)] | | 671.46 | triclinic | P1 | a 6.7493 b 10.8107 c 14.171 α 73.657° β 81.412° γ 75.206° Z=2 | 956.0 | 2.333 | yellow |